Biochemical and immunologic diagnosis of cancer. Myeloma

Inflammatory cytokine (interleukin 6 and tumour necrosis factor alpha) release in a human whole blood system in response to Streptococcus pneumoniae serotype 14 and its capsular polysaccharide.

Clinical and experimental immunology·2002

Limitations of Pneumovax as a detection antigen in the measurement of serotype-specific antibodies by enzyme-linked immunosorbent assay.

Annals of clinical biochemistry·2002

GM-CSF with biochemotherapy (cisplatin, DTIC, tamoxifen, IL-2 and interferon-alpha): a phase I trial in melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2000

Imaging and laboratory investigation in herpes simplex encephalitis.

Journal of neurology, neurosurgery, and psychiatry·1999

Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma.

Human gene therapy·1999

Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanoma.

British journal of cancer·1998

Beyond proficiency testing: Leveraging commutable External Quality Assessment data to harmonize tumor markers and refine medical decision points.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2026

Standardization of prostate-specific antigen assays: Impact on reference intervals and clinical decision thresholds.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2026

Digitoxin as a novel synergistic partner of cisplatin in triple-negative breast cancer (TNBC) cells.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2026

Tumour markers and evidence-based pathology.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2026

An integrated bioinformatics and multi-omics investigation of the sirtuin family to identify their prognostic importance in human cancers.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2025

Osteopontin-c gene expression and subcellular localization in ovarian cancer cells: Implications for prognosis and therapeutic responses.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2025

CMTM6 maintains B cell-intrinsic membrane CD40 stability to regulate anti-tumor immunity.

Acta pharmaceutica Sinica. B·2026

Thyroglobulin antibody in differentiated thyroid cancer: international laboratory practice survey and the case for a dual-threshold model.

Clinical chemistry and laboratory medicine·2026

Imiquimod triggers TLR7-independent apoptosis but TLR7-dependent activation in murine CD4+ T cells.

Biochemical and biophysical research communications·2026

Epidemiology and Survival Determinants of Monomorphic Epitheliotropic T-Cell Lymphoma: A Pooled Patient-Level Dataset Analysis.

Hematological oncology·2026

Imaging and Quantification of Immune Cells in the Tumor Microenvironment Using a Zebrafish Model of Neuroblastoma.

Journal of visualized experiments : JoVE·2026

T cell exhaustion in parasitic infections.

Frontiers in immunology·2026

Related Experiment Videos

Biochemical and immunologic diagnosis of cancer. Myeloma

Related Concept Videos

Inflammatory cytokine (interleukin 6 and tumour necrosis factor alpha) release in a human whole blood system in response to Streptococcus pneumoniae serotype 14 and its capsular polysaccharide.

Limitations of Pneumovax as a detection antigen in the measurement of serotype-specific antibodies by enzyme-linked immunosorbent assay.

GM-CSF with biochemotherapy (cisplatin, DTIC, tamoxifen, IL-2 and interferon-alpha): a phase I trial in melanoma.

Imaging and laboratory investigation in herpes simplex encephalitis.

Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma.

Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanoma.

Beyond proficiency testing: Leveraging commutable External Quality Assessment data to harmonize tumor markers and refine medical decision points.

Standardization of prostate-specific antigen assays: Impact on reference intervals and clinical decision thresholds.

Digitoxin as a novel synergistic partner of cisplatin in triple-negative breast cancer (TNBC) cells.

Tumour markers and evidence-based pathology.

An integrated bioinformatics and multi-omics investigation of the sirtuin family to identify their prognostic importance in human cancers.

Osteopontin-c gene expression and subcellular localization in ovarian cancer cells: Implications for prognosis and therapeutic responses.

CMTM6 maintains B cell-intrinsic membrane CD40 stability to regulate anti-tumor immunity.

Thyroglobulin antibody in differentiated thyroid cancer: international laboratory practice survey and the case for a dual-threshold model.

Imiquimod triggers TLR7-independent apoptosis but TLR7-dependent activation in murine CD4+ T cells.

Epidemiology and Survival Determinants of Monomorphic Epitheliotropic T-Cell Lymphoma: A Pooled Patient-Level Dataset Analysis.

Imaging and Quantification of Immune Cells in the Tumor Microenvironment Using a Zebrafish Model of Neuroblastoma.

T cell exhaustion in parasitic infections.

Related Experiment Videos

Biochemical and immunologic diagnosis of cancer. Myeloma

Related Concept Videos

Related Articles